The association between SPECC1L-ADORA2A (SPECC1L-ADORA2A Readthrough (NMD Candidate)) and Teebi Hypertelorism Syndrome 1 is supported by expert-curated evidence, drawing on a single expert-curated source, which records likely-pathogenic variants.
Sources1
Clinical variants44
Symptoms87
Compounds0
Trials0
Publications6
01
At a glance
Association overview
A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.